Editorial board

Journal Annals of Clinical Oncology (Ann Clin Oncol) (ISSN 2674-3248)

Aims and Scope

Annals of Clinical Oncology provides open access and efficient peer review process of publications on innovative current cancer treatment and various translation works dedicated to oncology and precision medicines.

The journal mainly focusses on clinical oncology, experimental oncology, cancer epidemiology, its diagnosis, treatment and prevention. The goal of the journal is to disseminate the discoveries of current clinical and experimental research in oncology, emphasizing on immunotherapy, experimental therapeutics, chemotherapy, molecular pathology, bioinformatics, modern statistics, and biotechnologies.

Annals of Clinical Oncology publishes a wide range of articles in this discipline covering all modern trends in Chemotherapy, Breast Cancer, Ovarian cancer, Lung Cancer, Brain Cancer, Surgical Oncology, Radiation Oncology, Paediatric Oncology, Haematology, Bone Marrow Transplantation, Malignant Tumours, Carcinogenesis - Etiology mechanisms, Molecular biology, Recent developments in tumor therapy, General diagnosis, Laboratory diagnosis, Diagnostic and experimental pathology, Gynecologic Cancers, Oncologic surgery, Cervix Cancer, Ovary Cancer, Colon & Rectum Cancer, Targeted Therapy. The scope of the journal is not limited to the listed research areas but covers a lot more areas globally.

All the work at Science Repository is licensed under a Creative Commons Attribution 4.0 International License. Authors at Science Repository retain copyright to their work and allow others to copy, distribute, transmit, and adapt their work, provided proper attribution is given. Electronic edition: online edition: ISSN 2674-3248

   
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. View License Deed | View Legal Code

For submission authors can directly submit manuscript to submitmanuscript@sciencerepository.org

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

• 14 day review process with international peer-review standards
• Timeline of processing from Submission to Publication is 30 days
• Manuscript will be published within 7 days of acceptance

In Press Volume 6, Issue 1

Editor-in-chief

MARIO SANTINAMI

Director

Foundation National Institute for the Study and Treatment of Tumors

Italy

Biography

Mario Santinami practices in Milan, Italy. His top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Adult Soft Tissue Sarcoma, and Metastatic Brain Tumor. His clinical research consists of co-authoring 84 peer reviewed articles and participating in 3 clinical trials in the past 15 years. Dr. Santinami deals with all the diagnostic and surgical clinical aspects concerning melanoma. The Melanoma and Sarcoma Complex Structure, directed by him, is a national and international reference center, guarantees patients innovative therapies in all phases of the disease with a high-quality standard and the possibility of accessing experimental treatments. Dr. Santinami deals with the research and surgery treatment of all skin cancers, both in adult and pediatric age. Within the structure he directs, the activity is aimed at both prevention and early diagnosis and treatment with the most advanced methodologies: sentinel lymph node, electrochemotherapy, establishment of complete databases that arrive at the digital archiving of images of suspicious lesions.

Current Issue Volume 5, Issue 2

Submit Manuscript

You can submit your manuscript at Science Repository. Authors submit manuscript files and metadata & can request for revision. Editors use the system to review submissions, assign to reviewers, and make and communicate decisions to accept, revise, transfer or reject manuscripts. Reviewers are invited to work on manuscripts, can accept or reject assignments.

For submission authors can directly submit manuscript to submitmanuscript@sciencerepository.org

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

• 14 day review process with international peer-review standards
• Timeline of processing from Submission to Publication is 30 days
• Manuscript will be published within 7 days of acceptance

Publication Charges

Annals of Clinical Oncology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License".

In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Annals of Clinical Oncology are £ (GBP) 1099.

Frequently Asked Questions (FAQs)

Why do we charge?

All articles published in Science Repository are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in Science Repository Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

• Maintain the portal for best experienece
• Recover capitalization cost
• Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development
• Although we charge the minimum possible but we will reduce the publication-charge cost downward over time.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

Who will pay the APC (Article Processing Charges)?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

• Online Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction gateway charges may be levied on the payee.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after processing of the manuscript.

Withdrawal Charges

Please check our Refund Policy

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

For more details you can refer to FAQs or contact us support@sciencerepository.org

Archive